OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contrasting Typical and Atypical Antipsychotic Drugs
Herbert Y. Meltzer, Erick Gadaleta
FOCUS The Journal of Lifelong Learning in Psychiatry (2021) Vol. 19, Iss. 1, pp. 3-13
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia
Agnieszka Matuszewska, Krzysztof Kowalski, Paulina Jawień, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6492-6492
Open Access | Times Cited: 18

The role of lumateperone in the treatment of schizophrenia
Alveena Batool Syed, James Robert Brašić
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 28

Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
Risa Yamada, Ayumu Wada, Andrew Stickley, et al.
The International Journal of Neuropsychopharmacology (2023) Vol. 26, Iss. 4, pp. 249-258
Open Access | Times Cited: 11

Cortisol in schizophrenia spectrum disorders: A comprehensive meta-analysis
Lydia Kogler, Rui Wang, Teresa Luther, et al.
Frontiers in Neuroendocrinology (2025) Vol. 77, pp. 101186-101186
Closed Access

Interictal psychosis of epilepsy: What is the role of the neurologist?
Luís Pintor, Felipe Castro Gutiérrez, Andrés M. Kanner
Epilepsy & Behavior Reports (2024) Vol. 28, pp. 100708-100708
Open Access | Times Cited: 2

Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
Risa Yamada, Ayumu Wada, Andrew Stickley, et al.
Schizophrenia Research Cognition (2023) Vol. 34, pp. 100290-100290
Open Access | Times Cited: 4

Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system
Sakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21891-e21891
Open Access | Times Cited: 4

Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map
Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, et al.
Cureus (2024)
Open Access | Times Cited: 1

Dopamine receptor 3: A mystery at the heart of cardiac fibrosis
Shannon E Byrne, Nandini Vishwakarma, Srinivas Sriramula, et al.
Life Sciences (2022) Vol. 308, pp. 120918-120918
Closed Access | Times Cited: 5

Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
Bhanu Gupta, K T Chee, Li-Qi Neo, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 6

Utilization of psychotropic medicines in Romania during 1998–2018
Irina Iaru, Camelia Bucșa, Andreea Farcaș, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2

Effect of Clozapine and 5-NT2A-Antagonist RU-31 on electroencephalography and Motor Activity of Rats in a Model of Schizophrenia with Neonatal Destruction of the Ventral Hippocampus
Konstantin Y. Kalitin, Г. В. Придворов, А. А. Спасов, et al.
Kuban Scientific Medical Bulletin (2022) Vol. 29, Iss. 5, pp. 108-122
Open Access | Times Cited: 3

Advances and Limitations on the Current Treatment for Schizophrenia and its Future Prospect
Jianning Li, Yunyang Zhang, Ruoyu Zhou
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 3, pp. 112-117
Open Access

Ocular toxicity of psychotropic medications in a tertiary hospital in Lagos, Nigeria
Modupe Balogun, Olurotimi Ayodele Coker
Romanian Journal of Ophthalmology (2024) Vol. 68, Iss. 2
Open Access

Comparing haloperidol with clozapine as treatments for schizophrenia
Bingzhi Liao
Theoretical and Natural Science (2024) Vol. 45, Iss. 1, pp. 9-20
Open Access

Pancitopenia asociada al uso de risperidona: informe de caso
Álvaro Vallejos Narváez, Daniel Prieto Vargas, Sofia Osório, et al.
Revista del Hospital Italiano de Buenos Aires (2024)
Open Access

The influence of antipsychotic type (typical vs. atypical) on quality of life among individuals with schizophrenia
Diana-Elena Nistor, Lavinia Horoșan, Mihai Saftencu, et al.
Romanian Journal of Psychiatry & Psychotherapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 1

The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia
Daria Kamaeva, Daria V. Kazantseva, Anastasiia S. Boiko, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1179-1179
Open Access

Genotoxic and Mutagenic Assessment of PT-31, a Molecule with Antipsychotic Potential
Cassiana Bigolin, Andriele Veiverberg, Gabriela Zimmermann Prado Rodrigues, et al.
Drug Delivery Letters (2023) Vol. 13, Iss. 4, pp. 322-328
Closed Access

Effect of a decoction of Lophira alata (Banks ex P. Gaertn) on the pharmacokinetics of risperidone: Study of a drug-herb interaction
Rukayyat Bukola Oloyede
Journal of Current Biomedical Research (2023) Vol. 3, Iss. 2, pp. 933-941
Open Access

Weight Gain, Mental Symptoms and Self-Esteem in Patients with Schizophrenia
Havva Gezgin Yazıcı, İsmail Volkan Şahiner, Müşerref DİDİN, et al.
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2022) Vol. 14, Iss. Ek 1, pp. 100-109
Open Access

Navigating the Novel Psychotropics
Boadie W. Dunlop
FOCUS The Journal of Lifelong Learning in Psychiatry (2021) Vol. 19, Iss. 1, pp. 1-2
Open Access

Page 1 - Next Page

Scroll to top